Montelukast with its Immuno-modulatory and Antiviral action is potential game changer in COVID-19


  1. The generic, cheap and easily available drug if proved useful can be game changer to win over COVID-19

  2. This cheap molecule is available in nooks are corner of India including villages. Why govt is promoting costly drugs like Remdesivir, Favipiravir, Tocilizumab and not promoting cheap, generic drug? Any Pharma / corporate lobbying angle?


Post a Comment